Purpose: The revised prescription drug labeling developed by the Food and Drug Administration (FDA) is described. Summary: A new FDA final rule, "Requirements on Content and Format of Labeling for ...
Four biosimilars for Stelara have launched in the United States this year following legal settlements with the reference ...
A bipartisan Senate bill dubbed the “Skinny Label, Big Savings Act” was introduced in January. The bill would expand the scope of protection ...
The U.S. Food and Drug Administration (FDA) has released several important updates addressing new medication approvals and ...